We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Rabeprazole for the prevention of pathologic and symptomatic relapse of erosive or ulcerative gastroesophageal reflux disease. Rebeprazole Study Group.
- Authors
Caos, A; Moskovitz, M; Dayal, Y; Perdomo, C; Niecestro, R; Barth, J
- Abstract
We evaluated the effectiveness and safety profile of 10 and 20 mg of rabeprazole, a new proton pump inhibitor, once daily versus placebo in preventing endoscopic and symptomatic relapse for up to 1 yr among patients with healed erosive or ulcerative gastroesophageal reflux disease (GERD).
- Publication
The American journal of gastroenterology, 2000, Vol 95, Issue 11, p3081
- ISSN
0002-9270
- Publication type
Journal Article
- DOI
10.1111/j.1572-0241.2000.03179.x